Skip to content

13F-HR filed by CAXTON CORP

CAXTON CORP filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 17 holding rows worth $39,149,854.

Accession
0000919574-23-001423
Filed
2023-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2022

A holdings report, 17 entries on the cover page, a total value of $39,149,854 stated on the cover page (in dollars after the unit check, H1), rows summing to $39,149,854 with VALUE read as dollars as filed, 13F file number 028-15293. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SAVARA INC805111101COM6,896,551$10,689,654dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
XERIS BIOPHARMA HOLDINGS INC98422E103COM6,039,028$8,031,907dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
SPY78462F103SHS15,947$6,098,611dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
REZOLUTE INC76200L309COMMON STOCK1,403,157$2,904,535dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
SCYNEXIS INC811292200COM NEW1,723,947$2,689,357dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
SPDR SER TR78468R556S&P OILGAS EXP17,500$2,377,900dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
VECTIVBIO HLDG AGH9060V101COM156,222$1,346,055dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
ARCELLX INC COMMON STOCK03940C100Stock36,302$1,124,640dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
ALPS ETF TR00162Q452ALERIAN MLP29,500$1,123,065dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
COMPASS THERAPEUTICS INC20454B104COM211,159$1,062,132dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
CABALETTA BIO INC12674W109COMMON STOCK84,728$783,735dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
MOLECULAR TEMPLATES INC608550109COM2,052,991$673,381dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
ALLAKOS INC01671P100COM18,271$153,840dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
ELEVATION ONCOLOGY INC COM28623U101Stock68,324$64,800dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
NEWAMSTERDAM PHARMA CO NV-27N62509117WTS21,333$17,795dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
BRIDGETOWN HOLDINGS LTDG1355U121*W EXP 09/30/20239,773$4,671dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
LANVIN GROUP HOLDINGS LIMITEG5380J118W EXP 01/14/20212,000$3,776dollars as filedThe filing omitted confidential holdings, a later amendment may add them.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-23-001423this filing2023-02-14acceptance time not in the bulk data set